Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)

Clinical trial NCT04979468 · UNKNOWN

Trial details

NCT number: NCT04979468
Sponsor: Societa' Italiana Di Malattie Infettive E Tropicali
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2021-03-23
Primary completion: 2023-04-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.